Skip to main content
OpenTrials

Clinical trial condition

Muscular Dystrophy, Duchenne

Explore clinical trials studying Muscular Dystrophy, Duchenne. Study availability and eligibility vary by location and protocol.

362 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Muscular Dystrophy, Duchenne trial results

Completed

Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

NCT03038399

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • University of California Davis Davis, California, United States
  • University of Florida Gainesville, Florida, United States
  • Nemours Children's Hospital Orlando, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States
View Trial Details
Completed

Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients

NCT02530905

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
View Trial Details
Completed

Study of Eteplirsen in DMD Patients

NCT02255552

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Rady Children's Hospital, U.C. San Diego San Diego, California, United States
View all 37 locations
View Trial Details
Completed

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

NCT02420379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy (DMD), Genetic Diseases, Inborn, +8 more
Locations
  • Neuromuscular Research Center of Arizona Phoenix, Arizona, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 13 locations
View Trial Details

Related conditions